Grove Bank & Trust Gilead Sciences, Inc. Transaction History

Grove Bank & Trust

$670 Million
Q3 2024

A detailed history of Grove Bank & Trust transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Grove Bank & Trust holds 2,027 shares of GILD stock, worth $185,166. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,027

Previous 2,185 7.23%

Holding current value

$185,166

Previous $149,000 13.42%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$66.59 - $83.99 $10,521 - $13,270	-158 Reduced 7.23%	2,027 $169,000
Q2 2024 Jul 24, 2024	SELL	$63.15 - $72.88 $63,465 - $73,244	-1,005 Reduced 31.5%	2,185 $149,000
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $356,038 - $434,180	-4,974 Reduced 60.93%	3,190 $233,000
Q4 2023 Jan 30, 2024	SELL	$73.27 - $83.09 $49,383 - $56,002	-674 Reduced 7.63%	8,164 $661,000
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $16,784 - $18,312	227 Added 2.64%	8,838 $662,000
Q2 2023 Jul 27, 2023	SELL	$76.01 - $86.7 $183,564 - $209,380	-2,415 Reduced 21.9%	8,611 $663,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $575,882 - $656,107	-7,449 Reduced 40.32%	11,026 $914,000
Q4 2022 Feb 03, 2023	SELL	$62.32 - $89.47 $38,139 - $54,755	-612 Reduced 3.21%	18,475 $1.59 Million
Q3 2022 Oct 28, 2022	BUY	$59.54 - $68.01 $181,775 - $207,634	3,053 Added 19.04%	19,087 $1.18 Million
Q2 2022 Jul 29, 2022	BUY	$57.72 - $65.01 $194,805 - $219,408	3,375 Added 26.66%	16,034 $991,000
Q1 2022 Apr 22, 2022	BUY	$57.92 - $72.58 $19,924 - $24,967	344 Added 2.79%	12,659 $753,000
Q4 2021 Jan 31, 2022	SELL	$64.88 - $73.64 $6,617 - $7,511	-102 Reduced 0.82%	12,315 $894,000
Q3 2021 Oct 28, 2021	BUY	$67.69 - $73.03 $22,202 - $23,953	328 Added 2.71%	12,417 $867,000
Q2 2021 Jul 28, 2021	BUY	$63.47 - $69.35 $73,815 - $80,654	1,163 Added 10.64%	12,089 $832,000
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $106,860 - $121,927	1,781 Added 19.48%	10,926 $706,000
Q4 2020 Feb 03, 2021	BUY	$56.65 - $64.55 $56,819 - $64,743	1,003 Added 12.32%	9,145 $533,000
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $207,848 - $261,333	3,347 Added 69.8%	8,142 $514,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $76,825 - $89,208	-1,062 Reduced 18.13%	4,795 $369,000
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $143,109 - $183,302	2,285 Added 63.97%	5,857 $438,000
Q4 2019 Feb 11, 2020	BUY	$61.62 - $67.78 $220,106 - $242,110	3,572 New	3,572 $232,000
Q1 2018 May 07, 2018	SELL	$72.84 - $88.8 $188,728 - $230,080	-2,591 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$71.15 - $83.52 $3,913 - $4,593	55 Added 2.17%	2,591 $186,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $182,870 - $216,751	2,536	2,536 $205,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account